Stay updated on Pembrolizumab in RCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in RCC Clinical Trial page.
Latest updates to the Pembrolizumab in RCC Clinical Trial page
- Check3 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. The update affects page metadata and formatting but does not alter study details, participation criteria, or study results.SummaryDifference0.1%
- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedFooter updates include adding 'Revision: v3.3.3' and removing the 'HHS Vulnerability Disclosure' link. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check47 days agoChange DetectedThe page shows a minor site update: Revision: v3.3.2 replacing v3.3.1; no study content or results are altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check54 days agoChange DetectedPublications section now states that some publications are voluntarily provided by those entering data and that PubMed-derived items are auto-filled. The Revision: v3.3.1 also notes that the list is automatically generated and may not always pertain to the study.SummaryDifference0.2%
- Check61 days agoChange DetectedRemoved the general government funding operating-status notice from the page. The study details, eligibility criteria, and results information remain unchanged.SummaryDifference0.4%
- Check75 days agoChange DetectedOnly minor textual/formatting changes are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
Stay in the know with updates to Pembrolizumab in RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in RCC Clinical Trial page.